nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—KCNH6—forebrain—autistic disorder	0.022	0.0652	CbGeAlD
Terazosin—KCNH6—telencephalon—autistic disorder	0.0203	0.0599	CbGeAlD
Terazosin—KCNH7—head—autistic disorder	0.0177	0.0524	CbGeAlD
Terazosin—KCNH7—nervous system—autistic disorder	0.0168	0.0497	CbGeAlD
Terazosin—KCNH7—central nervous system—autistic disorder	0.0162	0.0478	CbGeAlD
Terazosin—KCNH7—cerebellum—autistic disorder	0.0158	0.0467	CbGeAlD
Terazosin—Prazosin—HTR1D—autistic disorder	0.0134	1	CrCbGaD
Terazosin—KCNH7—brain—autistic disorder	0.0128	0.038	CbGeAlD
Terazosin—ADRA1A—hindbrain—autistic disorder	0.0127	0.0375	CbGeAlD
Terazosin—KCNH6—head—autistic disorder	0.0126	0.0373	CbGeAlD
Terazosin—ADRA1D—forebrain—autistic disorder	0.0122	0.0361	CbGeAlD
Terazosin—KCNH6—nervous system—autistic disorder	0.012	0.0354	CbGeAlD
Terazosin—KCNH6—central nervous system—autistic disorder	0.0115	0.0341	CbGeAlD
Terazosin—ADRA1D—telencephalon—autistic disorder	0.0112	0.0332	CbGeAlD
Terazosin—KCNH6—brain—autistic disorder	0.00915	0.027	CbGeAlD
Terazosin—ADRA1A—brainstem—autistic disorder	0.00727	0.0215	CbGeAlD
Terazosin—ADRA1B—head—autistic disorder	0.00715	0.0211	CbGeAlD
Terazosin—ADRA1A—forebrain—autistic disorder	0.00701	0.0207	CbGeAlD
Terazosin—ADRA1D—head—autistic disorder	0.00699	0.0207	CbGeAlD
Terazosin—ADRA1B—nervous system—autistic disorder	0.00678	0.02	CbGeAlD
Terazosin—KCNH2—forebrain—autistic disorder	0.00677	0.02	CbGeAlD
Terazosin—ADRA1D—nervous system—autistic disorder	0.00663	0.0196	CbGeAlD
Terazosin—ADRA1B—central nervous system—autistic disorder	0.00653	0.0193	CbGeAlD
Terazosin—ADRA1A—telencephalon—autistic disorder	0.00645	0.0191	CbGeAlD
Terazosin—ADRA1D—central nervous system—autistic disorder	0.00638	0.0189	CbGeAlD
Terazosin—KCNH2—telencephalon—autistic disorder	0.00623	0.0184	CbGeAlD
Terazosin—ADRA1B—brain—autistic disorder	0.00518	0.0153	CbGeAlD
Terazosin—ADRA1D—brain—autistic disorder	0.00507	0.015	CbGeAlD
Terazosin—ADRA1A—head—autistic disorder	0.00402	0.0119	CbGeAlD
Terazosin—KCNH2—head—autistic disorder	0.00388	0.0115	CbGeAlD
Terazosin—ADRA1A—nervous system—autistic disorder	0.00381	0.0113	CbGeAlD
Terazosin—KCNH2—nervous system—autistic disorder	0.00368	0.0109	CbGeAlD
Terazosin—ADRA1A—central nervous system—autistic disorder	0.00367	0.0108	CbGeAlD
Terazosin—ADRA1A—cerebellum—autistic disorder	0.00358	0.0106	CbGeAlD
Terazosin—KCNH2—central nervous system—autistic disorder	0.00354	0.0105	CbGeAlD
Terazosin—KCNH2—cerebellum—autistic disorder	0.00346	0.0102	CbGeAlD
Terazosin—ABCB1—forebrain—autistic disorder	0.00297	0.00879	CbGeAlD
Terazosin—ADRA1A—brain—autistic disorder	0.00291	0.00861	CbGeAlD
Terazosin—KCNH2—brain—autistic disorder	0.00281	0.00831	CbGeAlD
Terazosin—ABCB1—telencephalon—autistic disorder	0.00273	0.00808	CbGeAlD
Terazosin—ABCB1—digestive system—autistic disorder	0.00209	0.00617	CbGeAlD
Terazosin—ABCB1—head—autistic disorder	0.0017	0.00503	CbGeAlD
Terazosin—ABCB1—nervous system—autistic disorder	0.00161	0.00477	CbGeAlD
Terazosin—ABCB1—central nervous system—autistic disorder	0.00155	0.00459	CbGeAlD
Terazosin—ABCB1—cerebellum—autistic disorder	0.00152	0.00449	CbGeAlD
Terazosin—ABCB1—brain—autistic disorder	0.00123	0.00365	CbGeAlD
Terazosin—ADRA1B—Signaling by GPCR—DRD1—autistic disorder	0.00015	0.000231	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GRM5—autistic disorder	0.00015	0.000231	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—VIP—autistic disorder	0.00015	0.000231	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—DAO—autistic disorder	0.000148	0.000228	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—AVP—autistic disorder	0.000146	0.000226	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—DRD1—autistic disorder	0.000146	0.000226	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GRM8—autistic disorder	0.000146	0.000225	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—DRD3—autistic disorder	0.000145	0.000224	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—OXTR—autistic disorder	0.000145	0.000223	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SCT—autistic disorder	0.000143	0.000221	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—autistic disorder	0.000143	0.000221	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HTR1B—autistic disorder	0.000143	0.000221	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—OXT—autistic disorder	0.000143	0.000221	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—POMC—autistic disorder	0.000143	0.00022	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL5—autistic disorder	0.000142	0.000219	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—DRD3—autistic disorder	0.000142	0.000219	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—ADRB2—autistic disorder	0.000142	0.000218	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—UPB1—autistic disorder	0.000141	0.000218	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—WNT2—autistic disorder	0.000141	0.000218	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CALCA—autistic disorder	0.00014	0.000216	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR1D—autistic disorder	0.000139	0.000215	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GHR—autistic disorder	0.000139	0.000215	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—IL5—autistic disorder	0.000139	0.000214	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	0.000139	0.000214	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PDE4A—autistic disorder	0.000137	0.000212	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CALCA—autistic disorder	0.000137	0.000212	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—TF—autistic disorder	0.000137	0.000211	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ADM—autistic disorder	0.000137	0.000211	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GABBR1—autistic disorder	0.000137	0.000211	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—EIF4E—autistic disorder	0.000134	0.000207	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PRLR—autistic disorder	0.000134	0.000207	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—autistic disorder	0.000134	0.000206	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PDE4B—autistic disorder	0.000133	0.000206	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—AVP—autistic disorder	0.000133	0.000205	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—DRD1—autistic disorder	0.000133	0.000205	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	0.000133	0.000205	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ASMT—autistic disorder	0.000131	0.000203	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTM5—autistic disorder	0.000131	0.000203	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GRM8—autistic disorder	0.00013	0.0002	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—ADRB2—autistic disorder	0.000129	0.0002	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—OPRM1—autistic disorder	0.000129	0.000199	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—DRD3—autistic disorder	0.000129	0.000199	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AVPR1A—autistic disorder	0.000129	0.000198	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—autistic disorder	0.000127	0.000196	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—POMC—autistic disorder	0.000127	0.000196	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—autistic disorder	0.000127	0.000196	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL5—autistic disorder	0.000126	0.000194	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—WNT2—autistic disorder	0.000126	0.000194	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PLA2G4A—autistic disorder	0.000125	0.000193	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CALCA—autistic disorder	0.000125	0.000192	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—VIP—autistic disorder	0.000124	0.000191	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GRM5—autistic disorder	0.000124	0.000191	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GHR—autistic disorder	0.000124	0.000191	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SLC25A12—autistic disorder	0.000124	0.000191	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PDE4A—autistic disorder	0.000122	0.000188	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—HTR2A—autistic disorder	0.000122	0.000188	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—AVP—autistic disorder	0.000122	0.000187	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SLC19A1—autistic disorder	0.00012	0.000185	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—OXTR—autistic disorder	0.00012	0.000185	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SCT—autistic disorder	0.000119	0.000184	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GZMB—autistic disorder	0.000118	0.000182	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—ADRB2—autistic disorder	0.000117	0.000181	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	0.000115	0.000178	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—ADRB2—autistic disorder	0.000115	0.000177	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR1B—autistic disorder	0.000115	0.000177	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—OXT—autistic disorder	0.000115	0.000177	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AVPR1A—autistic disorder	0.000114	0.000176	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GABBR1—autistic disorder	0.000114	0.000175	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADM—autistic disorder	0.000114	0.000175	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EIF4E—autistic disorder	0.000112	0.000172	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HTR2A—autistic disorder	0.000111	0.000171	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PDE4B—autistic disorder	0.000111	0.000171	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	0.000111	0.000171	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AVP—autistic disorder	0.00011	0.00017	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—VIP—autistic disorder	0.00011	0.00017	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GRM5—autistic disorder	0.00011	0.00017	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	0.00011	0.00017	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AVP—autistic disorder	0.000108	0.000167	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ADSL—autistic disorder	0.000107	0.000165	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—OPRM1—autistic disorder	0.000107	0.000165	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PRKCB—autistic disorder	0.000107	0.000165	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—OXTR—autistic disorder	0.000107	0.000165	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—DRD1—autistic disorder	0.000107	0.000164	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TSC1—autistic disorder	0.000107	0.000164	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SCT—autistic disorder	0.000106	0.000163	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—XDH—autistic disorder	0.000105	0.000162	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—ADRB2—autistic disorder	0.000104	0.000161	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PLA2G4A—autistic disorder	0.000104	0.00016	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NTRK2—autistic disorder	0.000104	0.00016	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—DRD3—autistic disorder	0.000103	0.000159	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—STX1A—autistic disorder	0.000103	0.000159	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NPAS2—autistic disorder	0.000103	0.000159	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PIK3CG—autistic disorder	0.000102	0.000158	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	0.000102	0.000158	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—HTR2A—autistic disorder	0.000101	0.000156	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL5—autistic disorder	0.000101	0.000156	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GABBR1—autistic disorder	0.000101	0.000156	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADM—autistic disorder	0.000101	0.000156	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CALCA—autistic disorder	9.98e-05	0.000154	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—TCN2—autistic disorder	9.96e-05	0.000154	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EIF4E—autistic disorder	9.91e-05	0.000153	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PDE4B—autistic disorder	9.83e-05	0.000152	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AVP—autistic disorder	9.81e-05	0.000151	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GZMB—autistic disorder	9.8e-05	0.000151	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	9.78e-05	0.000151	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—POMC—autistic disorder	9.73e-05	0.00015	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PRKCB—autistic disorder	9.7e-05	0.00015	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—OPRM1—autistic disorder	9.52e-05	0.000147	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—OXT—autistic disorder	9.51e-05	0.000147	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR1B—autistic disorder	9.51e-05	0.000147	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ADA—autistic disorder	9.51e-05	0.000147	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—AVP—autistic disorder	9.5e-05	0.000147	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PIK3CG—autistic disorder	9.29e-05	0.000143	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PLA2G4A—autistic disorder	9.22e-05	0.000142	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HTR2A—autistic disorder	9.19e-05	0.000142	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	8.99e-05	0.000139	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—HTR2A—autistic disorder	8.98e-05	0.000139	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PRKCB—autistic disorder	8.87e-05	0.000137	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TSC1—autistic disorder	8.85e-05	0.000136	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—DRD1—autistic disorder	8.85e-05	0.000136	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—POMC—autistic disorder	8.84e-05	0.000136	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PRL—autistic disorder	8.81e-05	0.000136	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GZMB—autistic disorder	8.71e-05	0.000134	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—RORA—autistic disorder	8.67e-05	0.000134	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NTRK2—autistic disorder	8.6e-05	0.000133	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—DRD3—autistic disorder	8.57e-05	0.000132	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CG—autistic disorder	8.49e-05	0.000131	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR1B—autistic disorder	8.45e-05	0.00013	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—OXT—autistic disorder	8.45e-05	0.00013	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL5—autistic disorder	8.39e-05	0.000129	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ADRB2—autistic disorder	8.36e-05	0.000129	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CALCA—autistic disorder	8.28e-05	0.000128	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HTR2A—autistic disorder	8.16e-05	0.000126	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—MAOB—autistic disorder	8.12e-05	0.000125	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—POMC—autistic disorder	8.08e-05	0.000125	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PRKCB—autistic disorder	8.05e-05	0.000124	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PRKCB—autistic disorder	7.88e-05	0.000121	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TSC1—autistic disorder	7.86e-05	0.000121	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AVP—autistic disorder	7.86e-05	0.000121	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—DRD1—autistic disorder	7.86e-05	0.000121	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IGF2—autistic disorder	7.82e-05	0.000121	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CG—autistic disorder	7.71e-05	0.000119	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NTRK2—autistic disorder	7.64e-05	0.000118	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—DRD3—autistic disorder	7.61e-05	0.000117	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—TPH2—autistic disorder	7.55e-05	0.000116	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CG—autistic disorder	7.54e-05	0.000116	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL5—autistic disorder	7.45e-05	0.000115	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—DPYD—autistic disorder	7.43e-05	0.000115	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PLA2G4A—autistic disorder	7.39e-05	0.000114	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CALCA—autistic disorder	7.36e-05	0.000113	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—POMC—autistic disorder	7.34e-05	0.000113	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PRL—autistic disorder	7.32e-05	0.000113	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—IL2—autistic disorder	7.2e-05	0.000111	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MEF2C—autistic disorder	7.19e-05	0.000111	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—POMC—autistic disorder	7.18e-05	0.000111	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PRKCB—autistic disorder	7.15e-05	0.00011	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ITGB3—autistic disorder	7e-05	0.000108	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADRB2—autistic disorder	6.94e-05	0.000107	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CACNA1C—autistic disorder	6.91e-05	0.000107	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CG—autistic disorder	6.85e-05	0.000106	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR2A—autistic disorder	6.54e-05	0.000101	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL2—autistic disorder	6.53e-05	0.000101	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AVP—autistic disorder	6.52e-05	0.000101	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—POMC—autistic disorder	6.52e-05	0.0001	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PRL—autistic disorder	6.5e-05	0.0001	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IGF2—autistic disorder	6.49e-05	0.0001	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—DHFR—autistic disorder	6.28e-05	9.69e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TSC2—autistic disorder	6.21e-05	9.58e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADRB2—autistic disorder	6.17e-05	9.51e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PLA2G4A—autistic disorder	6.13e-05	9.46e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APOE—autistic disorder	6.08e-05	9.37e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—LEP—autistic disorder	6.08e-05	9.37e-05	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—IL2—autistic disorder	5.97e-05	9.21e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MEF2C—autistic disorder	5.96e-05	9.2e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ITGB3—autistic disorder	5.81e-05	8.96e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AVP—autistic disorder	5.79e-05	8.93e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IGF2—autistic disorder	5.77e-05	8.89e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PRKCB—autistic disorder	5.73e-05	8.84e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CG—autistic disorder	5.49e-05	8.46e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APC—autistic disorder	5.49e-05	8.46e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PLA2G4A—autistic disorder	5.45e-05	8.4e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR2A—autistic disorder	5.43e-05	8.37e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL2—autistic disorder	5.42e-05	8.36e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—EGF—autistic disorder	5.42e-05	8.36e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—IL2—autistic disorder	5.3e-05	8.18e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MEF2C—autistic disorder	5.3e-05	8.17e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—POMC—autistic disorder	5.22e-05	8.05e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ITGB3—autistic disorder	5.16e-05	7.96e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TSC2—autistic disorder	5.15e-05	7.95e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LEP—autistic disorder	5.04e-05	7.78e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOE—autistic disorder	5.04e-05	7.78e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IGF1—autistic disorder	5.02e-05	7.75e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—MAPK1—autistic disorder	5e-05	7.71e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP19A1—autistic disorder	4.92e-05	7.59e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR2A—autistic disorder	4.82e-05	7.43e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL2—autistic disorder	4.82e-05	7.43e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SERPINE1—autistic disorder	4.77e-05	7.36e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PRKCB—autistic disorder	4.76e-05	7.34e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TSC2—autistic disorder	4.58e-05	7.06e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—COMT—autistic disorder	4.58e-05	7.06e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTP1—autistic disorder	4.55e-05	7.02e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APC—autistic disorder	4.55e-05	7.02e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CG—autistic disorder	4.55e-05	7.02e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—MAOA—autistic disorder	4.54e-05	7.01e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EGF—autistic disorder	4.5e-05	6.94e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LEP—autistic disorder	4.48e-05	6.91e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOE—autistic disorder	4.48e-05	6.91e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CAT—autistic disorder	4.43e-05	6.83e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—POMC—autistic disorder	4.33e-05	6.68e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PRKCB—autistic disorder	4.23e-05	6.52e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PLA2G4A—autistic disorder	4.18e-05	6.45e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTM1—autistic disorder	4.18e-05	6.45e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IGF1—autistic disorder	4.17e-05	6.43e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—MAPK1—autistic disorder	4.15e-05	6.4e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CG—autistic disorder	4.04e-05	6.24e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APC—autistic disorder	4.04e-05	6.24e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HRAS—autistic disorder	4.01e-05	6.19e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GPX1—autistic disorder	4.01e-05	6.18e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EGF—autistic disorder	4e-05	6.16e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SERPINE1—autistic disorder	3.96e-05	6.1e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL2—autistic disorder	3.86e-05	5.95e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—POMC—autistic disorder	3.85e-05	5.94e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL6—autistic disorder	3.84e-05	5.92e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IGF1—autistic disorder	3.7e-05	5.71e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—MTHFR—autistic disorder	3.7e-05	5.7e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—MAPK1—autistic disorder	3.68e-05	5.68e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTEN—autistic disorder	3.63e-05	5.6e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SERPINE1—autistic disorder	3.52e-05	5.42e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOE—autistic disorder	3.44e-05	5.31e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HRAS—autistic disorder	3.33e-05	5.14e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL2—autistic disorder	3.2e-05	4.94e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6—autistic disorder	3.19e-05	4.92e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CG—autistic disorder	3.11e-05	4.79e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTEN—autistic disorder	3.01e-05	4.65e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HRAS—autistic disorder	2.96e-05	4.56e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—POMC—autistic disorder	2.96e-05	4.56e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MAPK1—autistic disorder	2.95e-05	4.55e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL2—autistic disorder	2.85e-05	4.39e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6—autistic disorder	2.83e-05	4.37e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTEN—autistic disorder	2.68e-05	4.13e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MAPK1—autistic disorder	2.45e-05	3.78e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HRAS—autistic disorder	2.37e-05	3.66e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTGS2—autistic disorder	2.36e-05	3.64e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6—autistic disorder	2.27e-05	3.5e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MAPK1—autistic disorder	2.18e-05	3.36e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTEN—autistic disorder	2.06e-05	3.17e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HRAS—autistic disorder	1.97e-05	3.03e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6—autistic disorder	1.88e-05	2.9e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HRAS—autistic disorder	1.75e-05	2.7e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6—autistic disorder	1.67e-05	2.58e-05	CbGpPWpGaD
